|
| 26967165 | Motivations for Intravaginal Product Use among a Cohort of Women in Los Angeles. | PLoS ONE | 2016 |
| 25356778 | Order of orifices: sequence of condom use and ejaculation by orifice during anal intercourse among women: implications for HIV transmission. | J Acquir Immune Defic Syndr | 2014 |
| 23635677 | Intravaginal practices and risk of bacterial vaginosis and candidiasis infection among a cohort of women in the United States. | Obstetrics and Gynecology | 2013 |
| 24334179 | Efficacy and safety of crofelemer for noninfectious diarrhea in HIV-seropositive individuals (ADVENT trial): a randomized, double-blind, placebo-controlled, two-stage study. | HIV Clinical Trials | 2013 |
| 22183849 | The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk. | Sex Transm Dis | 2012 |
| 22421748 | Sexual risk behaviors, circumcision status, and preexisting immunity to adenovirus type 5 among men who have sex with men participating in a randomized HIV-1 vaccine efficacy trial: step study. | J Acquir Immune Defic Syndr | 2012 |
| 21051598 | The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. | Science | 2010 |
| 18266604 | Safety, pharmacokinetics, and antiviral activity of HGS004, a novel fully human IgG4 monoclonal antibody against CCR5, in HIV-1-infected patients. | J Infect Dis | 2008 |
| 18045694 | Two-year prospective study of major depressive disorder in HIV-infected men. | J Affect Disord | 2008 |
| 18433307 | Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults. | Clin Infect Dis | 2008 |
| 17592343 | Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome: 12 week induction and 24-week maintenance therapy. | Journal of acquired immune deficiency syndromes (1999) | 2007 |
| 16936559 | Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals. | Journal of acquired immune deficiency syndromes (1999) | 2006 |
| 15173593 | CD4 on CD8(+) T cells directly enhances effector function and is a target for HIV infection. | Proceedings of the National Academy of Sciences of the United States of America | 2004 |
| 15385732 | Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. | J Acquir Immune Defic Syndr | 2004 |
| 15483468 | Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial. | J Acquir Immune Defic Syndr | 2004 |
| 15367617 | Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue. | Journal of Virology | 2004 |
| 15457682 | Mechanisms of HIV receptor and co-receptor down-regulation by prostratin: role of conventional and novel PKC isoforms. | Antiviral Chemistry and Chemotherapy | 2004 |
| 15456086 | Prostratin induces HIV activation and downregulates HIV receptors in peripheral blood lymphocytes. | Antiviral Therapy | 2004 |
| 14968938 | Potent and selective inhibition of HIV and SIV by prostratin interacting with viral entry. | Antiviral Chemistry and Chemotherapy | 2003 |
| 12134017 | Effects of prostratin on T-cell activation and human immunodeficiency virus latency. | Journal of Virology | 2002 |
| 9443710 | Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment. | Arch Neurol | 1998 |
| 8527076 | Early central nervous system response to HIV infection: sleep distortion and cognitive-motor decrements. | AIDS | 1995 |
| 8618848 | Sleep electroencephalogram delta-frequency amplitude, night plasma levels of tumor necrosis factor alpha, and human immunodeficiency virus infection. | Proc Natl Acad Sci U S A | 1995 |
| 7798087 | Psychiatric morbidity associated with acquired immune deficiency syndrome-related grief resolution. | J Nerv Ment Dis | 1995 |
| 8148632 | Postconcussional disorder: time to acknowledge a common source of neurobehavioral morbidity. | J Neuropsychiatry Clin Neurosci | 1994 |